At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
MightySatdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation
In Brief
A clinical study evaluating MightySat for Healthy. Completed, enrolled 88 participants across 1 site.
Detailed Summary
Evaluation of the noninvasive oxygen saturation (SpO2) performance of the noninvasive Masimo MightySat against reference arterial blood samples analyzed by a laboratory CO-oximeter reference instrument. The study will include different subgroups to assess the performance across different genders and skin pigmentation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedOct 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedOct 19, 2021
Enrollment StartOct 13, 2021
Primary CompletionDec 17, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.7 years ago
Interventions
MightySatdevice
Noninvasive pulse oximeter